Key result
The overall rate of perioperative adverse events in thoracic surgery was 0.2%, with cardiac arrest and massive haemorrhage being the major clinical manifestations.
Why the study?
Adverse events remain a major source of perioperative morbidity and mortality following thoracic surgery despite ongoing safety concerns.
What are the incidence, causes, and outcomes of perioperative adverse events in patients undergoing thoracic surgery?
Observational (n=62,571)
No
What are the incidence, causes, and outcomes of perioperative adverse events in patients undergoing thoracic surgery?
Perioperative adverse events in thoracic surgery are rare (0.2%) but carry significant mortality risk, primarily driven by surgery-related massive haemorrhage and cardiac arrest.
Requires heightened vigilance for arrest and haemorrhage in thoracic surgery; leaves open prospective studies on prevention.
OBJECTIVES: Despite a long history of concerns regarding patient safety during clinical care, some patients undergoing thoracic surgery continue to experience adverse events (AEs). AEs are a major significant source of perioperative morbidity and mortality following thoracic surgery. This study analysed the causes, treatment and prognosis of perioperative AEs to provide a reference for further surgical safety. METHODS: The authors collected a total of 62,571 thoracic surgery anaesthesia records via the Anaesthesia Information Management System (AIMS) from 14 August 2006 to 14 August 2017 and obtained 150 cases of perioperative serious AEs from the "adverse events registration" subsystem. The related hospitalization data of the 150 patients were analysed, including anaesthesia, recovery room time, ICU records and follow-up outcomes. The causes of these AEs were classified as follows: events related to the patients' pathogenic conditions(P); surgery-related factors(S); anaesthesia-related factors(A); and interactions between pathogenic, surgical and anaesthesia factors (P&S&A). We then analysed the main clinical manifestations, causes and treatment of these events. RESULTS: The overall rate of perioperative AEs in thoracic surgery (n = 62,571) was 0.2%. Of these, 10.7% were. caused by P and 23.3% by A; neither cause led to patient death. S and P&S&A accounted for 55.3 and 10.7% of AEs, respectively; together, they accounted for 66%. Twelve patients with postoperative AEs caused by S or P&S&A died within 3 days (8% of 150 cases). A total of 33%(50/150) of patients experienced sudden cardiac arrest (SCA) and recovered successfully. Surgical massive haemorrhage (22%, 33/150) was reported as a predominant mortality-related outcome in this group, and 8 of the 12 deaths were caused by massive haemorrhage. CONCLUSIONS: The rate of perioperative AEs after thoracic surgery was 0.2%. AEs must be identified and treated immediately. An important factor in anaesthesia-related events was respiratory management. Two major clinical manifestations of surgery-related events were cardiac arrest and massive haemorrhage. Cardiac arrest was the major factor contributing to AEs, but its adverse consequences could be avoided with timely discovery and proper treatment. Massive haemorrhage is a significant cause of mortality that can be prevented with a surgeon's early diagnosis and appropriate interventions.
No takes yet. Share an insight, caveat, or question.
Li et al. (2019) conducted an observational in Thoracic surgery (n=62,571). Thoracic surgery was evaluated on Perioperative adverse events. The overall rate of perioperative adverse events in thoracic surgery was 0.2%, with cardiac arrest and massive haemorrhage being the major clinical manifestations.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: